86 related articles for article (PubMed ID: 8617952)
1. Expression and characterization of functionally active recombinant perforin produced in insect cells.
Liu CC; Persechini PM; Young JD
J Immunol; 1996 May; 156(9):3292-300. PubMed ID: 8617952
[TBL] [Abstract][Full Text] [Related]
2. Characterization of recombinant mouse perforin expressed in insect cells using the baculovirus system.
Liu CC; Persechini PM; Young JD
Biochem Biophys Res Commun; 1994 May; 201(1):318-25. PubMed ID: 8198590
[TBL] [Abstract][Full Text] [Related]
3. Complement membrane attack complex, perforin, and bacterial exotoxins induce in K562 cells calcium-dependent cross-protection from lysis.
Reiter Y; Ciobotariu A; Jones J; Morgan BP; Fishelson Z
J Immunol; 1995 Aug; 155(4):2203-10. PubMed ID: 7636268
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells.
Oshimi Y; Oda S; Honda Y; Nagata S; Miyazaki S
J Immunol; 1996 Oct; 157(7):2909-15. PubMed ID: 8816396
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-15 induces the expression of mRNAs of cytolytic mediators and augments cytotoxic activities in primary murine lymphocytes.
Ye W; Young JD; Liu CC
Cell Immunol; 1996 Nov; 174(1):54-62. PubMed ID: 8929454
[TBL] [Abstract][Full Text] [Related]
6. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
[TBL] [Abstract][Full Text] [Related]
7. Perforin enhances the granulysin-induced lysis of Listeria innocua in human dendritic cells.
Walch M; Latinovic-Golic S; Velic A; Sundstrom H; Dumrese C; Wagner CA; Groscurth P; Ziegler U
BMC Immunol; 2007 Aug; 8():14. PubMed ID: 17705829
[TBL] [Abstract][Full Text] [Related]
8. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells.
Lee RK; Spielman J; Zhao DY; Olsen KJ; Podack ER
J Immunol; 1996 Sep; 157(5):1919-25. PubMed ID: 8757310
[TBL] [Abstract][Full Text] [Related]
9. Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade involving granzymes and perforin.
Brahmi Z; Csipo I; Bochan MR; Su B; Montel AH; Morse PA
Nat Immun; 1995 Sep; 14(5-6):271-85. PubMed ID: 8933821
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity.
Makrigiannis AP; Hoskin DW
J Immunol; 1997 Nov; 159(10):4700-7. PubMed ID: 9366393
[TBL] [Abstract][Full Text] [Related]
11. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
[TBL] [Abstract][Full Text] [Related]
12. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A
Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767
[TBL] [Abstract][Full Text] [Related]
13. Arrest of the cell cycle reduces susceptibility of target cells to perforin-mediated lysis.
De Leon M; Jackson KM; Cavanaugh JR; Mbangkollo D; Verret CR
J Cell Biochem; 1998 Jun; 69(4):425-35. PubMed ID: 9620169
[TBL] [Abstract][Full Text] [Related]
14. Two types of anti-TL (thymus leukemia) CTL clones with distinct target specificities: differences in cytotoxic mechanisms and accessory molecule requirements.
Tsujimura K; Takahashi T; Iwase S; Matsudaira Y; Kaneko Y; Yagita H; Obata Y
J Immunol; 1998 Jun; 160(11):5253-61. PubMed ID: 9605121
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY
J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of lymphocyte chymase I, a granzyme implicated in perforin-mediated lysis.
Woodard SL; Fraser SA; Winkler U; Jackson DS; Kam CM; Powers JC; Hudig D
J Immunol; 1998 May; 160(10):4988-93. PubMed ID: 9590247
[TBL] [Abstract][Full Text] [Related]
17. Structure and activity of the N-terminal region of the eukaryotic cytolysin equinatoxin II.
Drechsler A; Potrich C; Sabo JK; Frisanco M; Guella G; Dalla Serra M; Anderluh G; Separovic F; Norton RS
Biochemistry; 2006 Feb; 45(6):1818-28. PubMed ID: 16460028
[TBL] [Abstract][Full Text] [Related]
18. Homology of perforin to the ninth component of complement (C9).
Shinkai Y; Takio K; Okumura K
Nature; 1988 Aug; 334(6182):525-7. PubMed ID: 3261391
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
20. Expression and bioactivity of recombinant segments of human perforin.
Dong H; Xu X; Deng M; Yu X; Zhao H; Song H; Geng Y
Biochem Cell Biol; 2007 Apr; 85(2):203-8. PubMed ID: 17534401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
